Cargando…

Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease

Lafora disease (LD) is a fatal progressive epilepsy essentially caused by loss‐of‐function mutations in the glycogen phosphatase laforin or the ubiquitin E3 ligase malin. Glycogen in LD is hyperphosphorylated and poorly hydrosoluble. It precipitates and accumulates into neurotoxic Lafora bodies (LBs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nitschke, Felix, Sullivan, Mitchell A, Wang, Peixiang, Zhao, Xiaochu, Chown, Erin E, Perri, Ami M, Israelian, Lori, Juana‐López, Lucia, Bovolenta, Paola, Rodríguez de Córdoba, Santiago, Steup, Martin, Minassian, Berge A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494504/ https://www.ncbi.nlm.nih.gov/pubmed/28536304 http://dx.doi.org/10.15252/emmm.201707608

Ejemplares similares

Ketogenic diet reduces Lafora bodies in murine Lafora disease
por: Israelian, Lori, et al.
Publicado: (2020)

An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice
por: Nitschke, Silvia, et al.
Publicado: (2020)

Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan
por: Sullivan, Mitchell A., et al.
Publicado: (2017)

Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy
por: Mitra, Sharmistha, et al.
Publicado: (2023)

Everolimus does not prevent Lafora body formation in murine Lafora disease
por: Mishra, Navin, et al.
Publicado: (2017)

PTG Depletion Removes Lafora Bodies and Rescues the Fatal Epilepsy of Lafora Disease
por: Turnbull, Julie, et al.
Publicado: (2011)

Lafora disease in miniature Wirehaired Dachshunds
por: Swain, Lindsay, et al.
Publicado: (2017)

Retinal Phenotyping of a Murine Model of Lafora Disease
por: Vincent, Ajoy, et al.
Publicado: (2023)

Extraneurological sparing in long‐lived typical Lafora disease
por: Goldsmith, Danielle, et al.
Publicado: (2018)

Canine Lafora Disease: An Unstable Repeat Expansion Disorder
por: von Klopmann, Thilo, et al.
Publicado: (2021)

Nationwide genetic testing towards eliminating Lafora disease from Miniature Wirehaired Dachshunds in the United Kingdom
por: Ahonen, Saija, et al.
Publicado: (2018)

Correction to: Nationwide genetic testing towards eliminating Lafora disease from Miniature Wirehaired Dachshunds in the United Kingdom
por: Ahonen, Saija, et al.
Publicado: (2021)

Ocular phenotype and electroretinogram abnormalities in Lafora disease and correlation with disease stage
por: Orsini, Alessandro, et al.
Publicado: (2022)

Retinal alterations in patients with Lafora disease
por: Heitkotter, Heather, et al.
Publicado: (2021)

Role of Astrocytes in the Pathophysiology of Lafora Disease and Other Glycogen Storage Disorders
por: Duran, Jordi
Publicado: (2023)

Lafora progressive myoclonus epilepsy: NHLRC1 mutations affect glycogen metabolism
por: Couarch, Philippe, et al.
Publicado: (2011)

Dominant LMAN2L mutation causes intellectual disability with remitting epilepsy
por: Alkhater, Reem A., et al.
Publicado: (2019)

Genotypes and phenotypes of patients with Lafora disease living in Germany
por: Brenner, David, et al.
Publicado: (2019)

Diabetes Mellitus in a Patient With Lafora Disease: Possible Links With Pancreatic β-Cell Dysfunction and Insulin Resistance
por: Nicolescu, Ramona C., et al.
Publicado: (2019)

GYS1 or PPP1R3C deficiency rescues murine adult polyglucosan body disease
por: Chown, Erin E., et al.
Publicado: (2020)

Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease
por: Valles-Ortega, Jordi, et al.
Publicado: (2011)

Structural and Functional Brain Abnormalities in Mouse Models of Lafora Disease
por: Burgos, Daniel F., et al.
Publicado: (2020)

Lack of p62 Impairs Glycogen Aggregation and Exacerbates Pathology in a Mouse Model of Myoclonic Epilepsy of Lafora
por: Pellegrini, Pasquale, et al.
Publicado: (2021)

AAV-Mediated Artificial miRNA Reduces Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models
por: Gumusgoz, Emrah, et al.
Publicado: (2022)

Identification of proteins potentially involved in the formation of Lafora bodies, a hallmark of Lafora disease
por: Schokraie, Elham, et al.
Publicado: (2013)

Unusual Course of Lafora Disease
por: Zutt, Rodi, et al.
Publicado: (2016)

Role of Glycogen Synthase Kinase-3β in APP Hyperphosphorylation Induced by NMDA Stimulation in Cortical Neurons
por: Ploia, Cristina, et al.
Publicado: (2010)

Laforin, the most common protein mutated in Lafora disease, regulates autophagy
por: Aguado, Carmen, et al.
Publicado: (2010)

Clinicopathologic Dissociation: Robust Lafora Body Accumulation in Malin KO Mice Without Observable Changes in Home-cage Behavior
por: Krishnan, Vaishnav, et al.
Publicado: (2023)

Lafora Disease Masquerading as Hepatic Dysfunction
por: Inayat, Faisal, et al.
Publicado: (2018)

Lafora disease: a case report
por: Zeka, Naim, et al.
Publicado: (2022)

Vagus nerve stimulation in Lafora body disease()
por: Hajnsek, Sanja, et al.
Publicado: (2013)

Lafora Disease: A Ubiquitination-Related Pathology
por: García-Gimeno, Maria Adelaida, et al.
Publicado: (2018)

Treatment with metformin in twelve patients with Lafora disease
por: Bisulli, Francesca, et al.
Publicado: (2019)

Lafora Disease: Report of a Rare Entity
por: Al Mufargi, Younis, et al.
Publicado: (2020)

Trehalose Treatment in Zebrafish Model of Lafora Disease
por: Della Vecchia, Stefania, et al.
Publicado: (2022)

Gys1 Antisense Therapy Prevents Disease-Driving Aggregates and Epileptiform Discharges in a Lafora Disease Mouse Model
por: Donohue, Katherine J., et al.
Publicado: (2023)

Increased Endoplasmic Reticulum Stress and Decreased Proteasomal Function in Lafora Disease Models Lacking the Phosphatase Laforin
por: Vernia, Santiago, et al.
Publicado: (2009)

Activation of serum/glucocorticoid-induced kinase 1 (SGK1) underlies increased glycogen levels, mTOR activation, and autophagy defects in Lafora disease
por: Singh, Pankaj Kumar, et al.
Publicado: (2013)

Correction for Activation of serum/glucocorticoid-induced kinase 1 (SGK1) underlies increased glycogen levels, mTOR activation, and autophagy defects in Lafora disease
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_eo34kq1u8pqjpohod8rnjtklng